Document is current
Any future updates will be listed below
-
Authors
Liu, Xi
Zhang, Xue
Shang, Xue
Wang, Huihui
Hou, Wenting
Sun, Zhirong
-
Funding
Funding for this research was provided by:
Shanghai Anti-Cancer Association (SACA-CY20B06)
Wu Jieping Medical Foundation (320.6750.2020-21-6)
Natural Science Foundation of Shanghai (20ZR1412600)
National Key Research and Development Plan of China (2018YFC2001904)
- License Information
-
More Information
Article History
Received: 17 February 2023
Accepted: 28 July 2023
First Online: 23 August 2023
Declarations
:
: The authors declare no competing interests.
: for this study was provided by the ethics committee of Fudan University Shanghai Cancer Canter, Shanghai, China, on February 12, 2018 (Number 1712179-12-1802, Chairperson Prof. Chen Zhen) and registered at the Chinese Clinical Trial Registry (ChiCTR1800015797; ; Registered on 20/04/2018). Written informed consent for all forms of personally identifiable data including clinical, and biometric data was obtained from all patients. Any minor or illiterate person participating in the study has obtained the informed consent of a legally authorized representative or guardian. All methods in this study were performed in accordance with the relevant guidelines and regulation.
: Not Applicable.
